Khiron Life Sciences's total assets for Q3 2022 were C$38.45M, a decrease of -4.44% from the previous quarter. KHRNF total liabilities were C$11.35M for the fiscal quarter, a 9.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.